MCHPP vs AMAT
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 26, 2026
MCHPP
45.6
AI Score
VS
AMAT Wins
AMAT
52.0
AI Score
Investment Advisor Scores
AMAT
52score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | MCHPP | AMAT | Winner |
|---|---|---|---|
| Revenue | 1.48B | 24.04B | AMAT |
| Net Income | 229.80M | 7.37B | AMAT |
| Gross Margin | 63.2% | 49.8% | MCHPP |
| Net Margin | 15.5% | 30.7% | AMAT |
| Operating Income | 336.80M | 7.43B | AMAT |
| ROE | 3.6% | 28.8% | AMAT |
| ROA | 1.6% | 16.9% | AMAT |
| Total Assets | 14.41B | 43.52B | AMAT |
| Cash | 272.30M | 7.04B | AMAT |
| Debt/Equity | 0.83 | 0.20 | AMAT |
| Current Ratio | 1.92 | 2.42 | AMAT |
| Free Cash Flow | 497.60M | 3.58B | AMAT |
Relative Price Performance (Last 90 Days)
MCHPP 1M: -0.4%
· 3M: -4.3%
AMAT 1M: -20.5%
· 3M: -27.0%
Current Technical Phase
MCHPP
DistributionTrim / tighten stop
Price near a flattening SMA50 (slope -1.2%) with fading momentum, RSI 46
AMAT
MarkdownSell / avoid
Price below a falling SMA50 (slope -4.5%), weak momentum, RSI 26
Fundamentals Snapshot
| Metric | MCHPP | AMAT |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 20.4 |
| Trailing P/E | — | 35.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.2% |
| Gross Margin | 0.6% | 0.5% |
| Operating Margin | 0.2% | 0.3% |
| EPS | 0.00 | 10.64 |
| Dividend Yield | 0.03% | 0.00% |
Frequently Asked Questions
Based on our detailed analysis, AMAT is currently the stronger investment candidate, winning 11 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.